New study aims to understand severe breathing crises in kids with lung condition
NCT ID NCT07666438
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares severe respiratory infections in children with bronchopulmonary dysplasia (BPD) to those without BPD. Researchers will look back at past cases and follow new cases until 2030. The goal is to learn what makes these infections more dangerous for children with BPD, which could improve care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and manage severe breathing problems in children with BPD.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve outcomes. Results may take years and might not apply to all children with BPD.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 800 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children with bronchopulmonary dysplasia and respiratory exacerbation, and Children without bronchopulmonary dysplasia admitted for respiratory exacerbation.
- Ages
-
30 days to 7 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Corrected age ≥30 days and ≤7 years Acute lower respiratory tract infection At least one of: tachypnea for age SpO2 \<94% increased work of breathing Gestational age \<32 weeks Diagnosis of bronchopulmonary dysplasia according to NICHD 2018 definition Exclusion Criteria: * Grade ≥3 intraventricular hemorrhage Major congenital heart disease Neuromuscular disorders Chromosomal/genetic syndromes Primary pulmonary diseases Major skeletal dysplasia
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bronchopulmonary dysplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
IRCCS Azienda Ospedaliero - Universitaria di Bologna, U.O. Pediatria
RECRUITINGBologna, Bologna, 40138, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Why do some preterm babies need breathing machines longer?
- A Baby's fidgets may reveal brain health: study tests early warning signs
- Could a lung ultrasound spot preemie lung disease before it starts?
- Could a Mother's Omega-3 supplement shield preterm Babies' lungs?
- A new MRI test could spot a hidden Heart-Lung danger in babies
- Early therapy may rewire motor development in premature infants